Versant Venture Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-101,855	Closed	-$121K	–	8
2022 Q3	$121K	Hold	101,855	–	–	0.21%	8
2022 Q2	$183K	Hold	101,855	–	–	0.28%	8
2022 Q1	$206K	Hold	101,855	–	–	0.21%	10
2021 Q4	$276K	Hold	101,855	–	–	0.15%	10
2021 Q3	$454K	Hold	101,855	–	–	0.19%	11
2021 Q2	$591K	Hold	101,855	–	–	0.2%	11
2021 Q1	$715K	Hold	101,855	–	–	0.14%	11
2020 Q4	$489K	Hold	101,855	–	–	0.05%	12
2020 Q3	$594K	Hold	101,855	–	–	0.11%	10
2020 Q2	$688K	Hold	101,855	–	–	0.1%	11
2020 Q1	$648K	Hold	101,855	–	–	0.18%	8
2019 Q4	$1.06M	Hold	101,855	–	–	0.32%	7
2019 Q3	$400K	Hold	101,855	–	–	0.15%	8
2019 Q2	$1.51M	Hold	101,855	–	–	0.44%	8
2019 Q1	$2.53M	Hold	101,855	–	–	0.83%	7
2018 Q4	$1.83M	Hold	101,855	–	–	0.91%	8
2018 Q3	$2.99M	Hold	101,855	–	–	1.02%	9
2018 Q2	$4.63M	Hold	101,855	–	–	1.44%	8
2018 Q1	$5.38M	Hold	101,855	–	–	1.72%	8
2017 Q4	$6.93M	Hold	101,855	–	–	7.29%	7
2017 Q3	$8.38M	Hold	101,855	–	–	6.38%	5
2017 Q2	$9.54M	Sell	101,855 -305,561	-75%	-$18.7M	7.51%	5
2017 Q1	$25.9M	Hold	407,416	–	–	18.86%	3
2016 Q4	$18.1M	Hold	407,416	–	–	17.61%	3
2016 Q3	$14.7M	Hold	407,416	–	–	16.38%	4
2016 Q2	$5.59M	Hold	407,416	–	–	5.66%	3
2016 Q1	$7.82M	Hold	407,416	–	–	5.65%	4
2015 Q4	$14.3M	Hold	407,416	–	–	8.34%	4
2015 Q3	$37.5M	Hold	407,416	–	–	21.49%	2
2015 Q2	$35.8M	Sell	407,416 -407,417	-50%	-$34.9M	45.41%	1
2015 Q1	$60.5M	Hold	814,833	–	–	53.2%	1
2014 Q4	$45.6M	Buy	+814,833	New	+$42.8M	43.63%	1